ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 44 filers reported holding ONCOCYTE CORP in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $282,567 | -19.7% | 1,228,553 | +23.8% | 0.00% | – |
| Q1 2023 | $351,725 | +110505.3% | 992,454 | 0.0% | 0.00% | – |
| Q4 2022 | $318 | -100.0% | 992,454 | -0.3% | 0.00% | – |
| Q3 2022 | $726,000 | -17.0% | 994,954 | +2.2% | 0.00% | – |
| Q2 2022 | $875,000 | -53.6% | 973,322 | -23.1% | 0.00% | – |
| Q1 2022 | $1,887,000 | -28.7% | 1,266,447 | +3.9% | 0.00% | – |
| Q4 2021 | $2,646,000 | -35.7% | 1,219,404 | +5.4% | 0.00% | -100.0% |
| Q3 2021 | $4,118,000 | -41.1% | 1,156,834 | -5.0% | 0.00% | 0.0% |
| Q2 2021 | $6,988,000 | +18.0% | 1,217,472 | +6.7% | 0.00% | 0.0% |
| Q1 2021 | $5,922,000 | +227.0% | 1,141,078 | +50.6% | 0.00% | – |
| Q4 2020 | $1,811,000 | +121.7% | 757,761 | +28.8% | 0.00% | – |
| Q3 2020 | $817,000 | -10.4% | 588,327 | +23.2% | 0.00% | – |
| Q2 2020 | $912,000 | +13.7% | 477,589 | +45.9% | 0.00% | – |
| Q1 2020 | $802,000 | -43.0% | 327,358 | -47.7% | 0.00% | – |
| Q4 2019 | $1,406,000 | +119.3% | 625,530 | +104.6% | 0.00% | – |
| Q3 2019 | $641,000 | -15.7% | 305,692 | +0.1% | 0.00% | – |
| Q2 2019 | $760,000 | +8.7% | 305,420 | +72.3% | 0.00% | – |
| Q1 2019 | $699,000 | +1564.3% | 177,211 | +473.5% | 0.00% | – |
| Q4 2018 | $42,000 | +10.5% | 30,902 | +100.0% | 0.00% | – |
| Q3 2018 | $38,000 | -2.6% | 15,451 | -0.6% | 0.00% | – |
| Q2 2018 | $39,000 | -22.0% | 15,544 | -34.8% | 0.00% | – |
| Q1 2018 | $50,000 | -51.5% | 23,855 | +7.6% | 0.00% | – |
| Q4 2017 | $103,000 | -38.0% | 22,179 | +0.7% | 0.00% | – |
| Q3 2017 | $166,000 | +49.5% | 22,016 | +2.5% | 0.00% | – |
| Q2 2017 | $111,000 | +24.7% | 21,474 | +43.5% | 0.00% | – |
| Q1 2017 | $89,000 | -15.2% | 14,961 | 0.0% | 0.00% | – |
| Q4 2016 | $105,000 | +40.0% | 14,961 | 0.0% | 0.00% | – |
| Q3 2016 | $75,000 | +41.5% | 14,961 | 0.0% | 0.00% | – |
| Q2 2016 | $53,000 | -34.6% | 14,961 | -15.6% | 0.00% | – |
| Q1 2016 | $81,000 | – | 17,733 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 23,353,697 | $17,048,000 | 1.30% |
| AWM Investment Company, Inc. | 7,746,557 | $5,655,000 | 0.86% |
| PURA VIDA INVESTMENTS, LLC | 18,056,274 | $13,181,000 | 0.76% |
| Defender Capital, LLC. | 2,551,980 | $1,883,000 | 0.74% |
| Penbrook Management LLC | 563,350 | $411,000 | 0.35% |
| ACT CAPITAL MANAGEMENT, LLC | 330,000 | $241,000 | 0.33% |
| CALIBER WEALTH MANAGEMENT, LLC | 75,120 | $55,000 | 0.04% |
| Fort Sheridan Advisors LLC | 135,000 | $99,000 | 0.03% |
| Orbimed Advisors | 1,882,768 | $1,374,000 | 0.03% |
| WEALTH EFFECTS LLC | 51,000 | $37,000 | 0.02% |